Table 1

Comorbidities and concomitant medications during 1-30 days and 91-120 days prior to new AMI hospitalization

N = 8,354

Case period

1-30 days before index day

Control period

91-120 days before index day


Comorbidity (%)

Hypertension

41.81

36.65

Diabetes mellitus

23.23

21.58

Osteoarthritis

8.55

7.79

Peptic ulcer disease

7.94

7.17

Chronic lung disease

6.48

6.12

Congestive heart failure

4.30

3.51

Chronic renal disease

3.17

2.82

Chronic liver disease

3.10

2.98

Atrial fibrillation

2.21

1.86

Rheumatoid arthritis

0.81

0.72

Migraine

0.65

0.41

Cancer

0.16

0.16

Concomitant medication (%)

calcium channel blocker

27.16

24.34

ACE inhibitors or ARBs

23.93

20.68

beta-blocker

22.06

17.05

sulfonylurea

15.75

14.97

statins

11.31

10.16

low dose aspirin

7.23

7.88

antihypertensive agents

5.12

4.31

insulin

4.39

3.58

thiazolidinediones

2.54

2.56

glinides

1.83

1.62

loop diuretics

1.59

1.28

non-aspirin antiplatelet agents

1.11

1.21

vitamin k antagonist

0.81

0.67


ACE: angiotensin converting enzyme; ARB: angiotensin receptor blocker

Shau et al. BMC Cardiovascular Disorders 2012 12:4   doi:10.1186/1471-2261-12-4

Open Data